A Rare Case of Metastatic Spiradenocarcinoma With CDKN2A Mutation.
Oncology (Williston Park)
; 38(6): 230-231, 2024 06 10.
Article
em En
| MEDLINE
| ID: mdl-38899982
ABSTRACT
Spiradenocarcinomas are rare malignant skin adnexal tumors. We describe a novel case of a patient with an aggressive CDKN2A-mutated spiradenocarcinoma who responded to a CDK4/6 inhibitor. This case highlights the unique nature of spiradenocarcinomas as well as the potential benefit of targeted therapy.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Inibidor p16 de Quinase Dependente de Ciclina
/
Mutação
Limite:
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article